nodes	percent_of_prediction	percent_of_DWPC	metapath
Abiraterone—Testosterone—Medroxyprogesterone Acetate—uterine cancer	0.218	0.534	CrCrCtD
Abiraterone—Testosterone—Progesterone—uterine cancer	0.19	0.466	CrCrCtD
Abiraterone—CYP17A1—Progesterone—uterine cancer	0.172	0.372	CbGbCtD
Abiraterone—ABCC1—Progesterone—uterine cancer	0.0586	0.127	CbGbCtD
Abiraterone—ABCC1—Dactinomycin—uterine cancer	0.0464	0.101	CbGbCtD
Abiraterone—ABCC1—Epirubicin—uterine cancer	0.0336	0.073	CbGbCtD
Abiraterone—CYP2C8—Medroxyprogesterone Acetate—uterine cancer	0.0315	0.0684	CbGbCtD
Abiraterone—ABCC1—Etoposide—uterine cancer	0.0262	0.0568	CbGbCtD
Abiraterone—CYP2C8—Progesterone—uterine cancer	0.0209	0.0453	CbGbCtD
Abiraterone—ABCC1—Doxorubicin—uterine cancer	0.0179	0.0388	CbGbCtD
Abiraterone—CYP2D6—Progesterone—uterine cancer	0.0133	0.0289	CbGbCtD
Abiraterone—CYP3A4—Medroxyprogesterone Acetate—uterine cancer	0.0128	0.0277	CbGbCtD
Abiraterone—CYP2C8—Etoposide—uterine cancer	0.00934	0.0203	CbGbCtD
Abiraterone—CYP3A4—Progesterone—uterine cancer	0.00847	0.0184	CbGbCtD
Abiraterone—CYP2D6—Doxorubicin—uterine cancer	0.00406	0.00881	CbGbCtD
Abiraterone—CYP3A4—Etoposide—uterine cancer	0.00379	0.00822	CbGbCtD
Abiraterone—CYP3A4—Doxorubicin—uterine cancer	0.00258	0.0056	CbGbCtD
Abiraterone—Hypernatraemia—Progesterone—uterine cancer	0.00171	0.0254	CcSEcCtD
Abiraterone—Joint swelling—Medroxyprogesterone Acetate—uterine cancer	0.00166	0.0247	CcSEcCtD
Abiraterone—Hypernatraemia—Medroxyprogesterone Acetate—uterine cancer	0.00155	0.023	CcSEcCtD
Abiraterone—SULT2A1—female reproductive system—uterine cancer	0.00135	0.112	CbGeAlD
Abiraterone—SULT2A1—female gonad—uterine cancer	0.00123	0.102	CbGeAlD
Abiraterone—Testosterone—CYP11A1—uterine cancer	0.000982	0.659	CrCbGaD
Abiraterone—Nocturia—Progesterone—uterine cancer	0.000969	0.0144	CcSEcCtD
Abiraterone—Fluid retention—Progesterone—uterine cancer	0.000853	0.0127	CcSEcCtD
Abiraterone—Hepatotoxicity—Dactinomycin—uterine cancer	0.000823	0.0122	CcSEcCtD
Abiraterone—Phosphatase alkaline increased—Medroxyprogesterone Acetate—uterine cancer	0.000814	0.0121	CcSEcCtD
Abiraterone—SULT2A1—lymph node—uterine cancer	0.000789	0.0658	CbGeAlD
Abiraterone—Fluid retention—Medroxyprogesterone Acetate—uterine cancer	0.000773	0.0115	CcSEcCtD
Abiraterone—CYP17A1—renal system—uterine cancer	0.000733	0.0611	CbGeAlD
Abiraterone—Hot flush—Progesterone—uterine cancer	0.000697	0.0104	CcSEcCtD
Abiraterone—Menopausal symptoms—Progesterone—uterine cancer	0.000691	0.0103	CcSEcCtD
Abiraterone—Blood alkaline phosphatase increased—Medroxyprogesterone Acetate—uterine cancer	0.00068	0.0101	CcSEcCtD
Abiraterone—Hot flush—Medroxyprogesterone Acetate—uterine cancer	0.000632	0.00939	CcSEcCtD
Abiraterone—Menopausal symptoms—Medroxyprogesterone Acetate—uterine cancer	0.000626	0.00931	CcSEcCtD
Abiraterone—Infection—Carboplatin—uterine cancer	0.000606	0.00901	CcSEcCtD
Abiraterone—Hepatotoxicity—Etoposide—uterine cancer	0.000595	0.00885	CcSEcCtD
Abiraterone—Aspartate aminotransferase increased—Progesterone—uterine cancer	0.000587	0.00873	CcSEcCtD
Abiraterone—CYP17A1—female reproductive system—uterine cancer	0.000587	0.0489	CbGeAlD
Abiraterone—Nasopharyngitis—Progesterone—uterine cancer	0.000583	0.00867	CcSEcCtD
Abiraterone—Alanine aminotransferase increased—Progesterone—uterine cancer	0.000575	0.00855	CcSEcCtD
Abiraterone—Hypokalaemia—Medroxyprogesterone Acetate—uterine cancer	0.000538	0.00799	CcSEcCtD
Abiraterone—CYP17A1—female gonad—uterine cancer	0.000534	0.0445	CbGeAlD
Abiraterone—Nasopharyngitis—Medroxyprogesterone Acetate—uterine cancer	0.000529	0.00785	CcSEcCtD
Abiraterone—Upper respiratory tract infection—Progesterone—uterine cancer	0.000524	0.00779	CcSEcCtD
Abiraterone—Alanine aminotransferase increased—Medroxyprogesterone Acetate—uterine cancer	0.000521	0.00775	CcSEcCtD
Abiraterone—Pollakiuria—Progesterone—uterine cancer	0.000521	0.00774	CcSEcCtD
Abiraterone—Chest discomfort—Etoposide—uterine cancer	0.00052	0.00772	CcSEcCtD
Abiraterone—ABCC1—myometrium—uterine cancer	0.000512	0.0426	CbGeAlD
Abiraterone—Hyperglycaemia—Progesterone—uterine cancer	0.000509	0.00756	CcSEcCtD
Abiraterone—Testosterone—CYP19A1—uterine cancer	0.000508	0.341	CrCbGaD
Abiraterone—Pneumonia—Progesterone—uterine cancer	0.000506	0.00751	CcSEcCtD
Abiraterone—Lymphopenia—Epirubicin—uterine cancer	0.000504	0.00748	CcSEcCtD
Abiraterone—Infestation NOS—Progesterone—uterine cancer	0.000503	0.00747	CcSEcCtD
Abiraterone—Infestation—Progesterone—uterine cancer	0.000503	0.00747	CcSEcCtD
Abiraterone—ORM1—endometrium—uterine cancer	0.000498	0.0415	CbGeAlD
Abiraterone—Hypernatraemia—Epirubicin—uterine cancer	0.00049	0.00728	CcSEcCtD
Abiraterone—Urinary tract infection—Progesterone—uterine cancer	0.000489	0.00726	CcSEcCtD
Abiraterone—Body temperature increased—Carboplatin—uterine cancer	0.000482	0.00717	CcSEcCtD
Abiraterone—Upper respiratory tract infection—Medroxyprogesterone Acetate—uterine cancer	0.000475	0.00706	CcSEcCtD
Abiraterone—Pollakiuria—Medroxyprogesterone Acetate—uterine cancer	0.000472	0.00701	CcSEcCtD
Abiraterone—Lymphopenia—Doxorubicin—uterine cancer	0.000466	0.00692	CcSEcCtD
Abiraterone—Hyperglycaemia—Medroxyprogesterone Acetate—uterine cancer	0.000461	0.00685	CcSEcCtD
Abiraterone—Phosphatase alkaline increased—Etoposide—uterine cancer	0.00046	0.00683	CcSEcCtD
Abiraterone—Infestation NOS—Medroxyprogesterone Acetate—uterine cancer	0.000456	0.00677	CcSEcCtD
Abiraterone—Infestation—Medroxyprogesterone Acetate—uterine cancer	0.000456	0.00677	CcSEcCtD
Abiraterone—Hypernatraemia—Doxorubicin—uterine cancer	0.000453	0.00674	CcSEcCtD
Abiraterone—Acute coronary syndrome—Medroxyprogesterone Acetate—uterine cancer	0.000449	0.00667	CcSEcCtD
Abiraterone—Myocardial infarction—Medroxyprogesterone Acetate—uterine cancer	0.000447	0.00664	CcSEcCtD
Abiraterone—Urinary tract disorder—Progesterone—uterine cancer	0.000446	0.00662	CcSEcCtD
Abiraterone—Connective tissue disorder—Progesterone—uterine cancer	0.000443	0.00659	CcSEcCtD
Abiraterone—Hypophosphataemia—Epirubicin—uterine cancer	0.000443	0.00659	CcSEcCtD
Abiraterone—Urinary tract infection—Medroxyprogesterone Acetate—uterine cancer	0.000443	0.00658	CcSEcCtD
Abiraterone—Urethral disorder—Progesterone—uterine cancer	0.000442	0.00657	CcSEcCtD
Abiraterone—Cardiac disorder—Progesterone—uterine cancer	0.000419	0.00622	CcSEcCtD
Abiraterone—Aspartate aminotransferase increased—Dactinomycin—uterine cancer	0.000415	0.00617	CcSEcCtD
Abiraterone—ORM1—female reproductive system—uterine cancer	0.000412	0.0344	CbGeAlD
Abiraterone—Hypophosphataemia—Doxorubicin—uterine cancer	0.00041	0.0061	CcSEcCtD
Abiraterone—Angiopathy—Progesterone—uterine cancer	0.000409	0.00608	CcSEcCtD
Abiraterone—Mediastinal disorder—Progesterone—uterine cancer	0.000407	0.00604	CcSEcCtD
Abiraterone—Urinary tract disorder—Medroxyprogesterone Acetate—uterine cancer	0.000404	0.006	CcSEcCtD
Abiraterone—Connective tissue disorder—Medroxyprogesterone Acetate—uterine cancer	0.000402	0.00597	CcSEcCtD
Abiraterone—Urethral disorder—Medroxyprogesterone Acetate—uterine cancer	0.000401	0.00596	CcSEcCtD
Abiraterone—ABCC1—uterine cervix—uterine cancer	0.000398	0.0332	CbGeAlD
Abiraterone—Mental disorder—Progesterone—uterine cancer	0.000395	0.00588	CcSEcCtD
Abiraterone—Blood alkaline phosphatase increased—Etoposide—uterine cancer	0.000384	0.0057	CcSEcCtD
Abiraterone—Cardiac disorder—Medroxyprogesterone Acetate—uterine cancer	0.00038	0.00564	CcSEcCtD
Abiraterone—ABCC1—decidua—uterine cancer	0.000379	0.0316	CbGeAlD
Abiraterone—Angiopathy—Medroxyprogesterone Acetate—uterine cancer	0.000371	0.00551	CcSEcCtD
Abiraterone—Mediastinal disorder—Medroxyprogesterone Acetate—uterine cancer	0.000369	0.00548	CcSEcCtD
Abiraterone—Anaemia—Progesterone—uterine cancer	0.000363	0.0054	CcSEcCtD
Abiraterone—ABCC1—endometrium—uterine cancer	0.00036	0.03	CbGeAlD
Abiraterone—Mental disorder—Medroxyprogesterone Acetate—uterine cancer	0.000358	0.00532	CcSEcCtD
Abiraterone—Pneumonia—Dactinomycin—uterine cancer	0.000357	0.00531	CcSEcCtD
Abiraterone—ABCC1—mammalian vulva—uterine cancer	0.000348	0.029	CbGeAlD
Abiraterone—CYP17A1—lymph node—uterine cancer	0.000343	0.0286	CbGeAlD
Abiraterone—Cough—Progesterone—uterine cancer	0.000343	0.00509	CcSEcCtD
Abiraterone—Cardiac failure—Etoposide—uterine cancer	0.000342	0.00508	CcSEcCtD
Abiraterone—Hypertension—Progesterone—uterine cancer	0.000339	0.00504	CcSEcCtD
Abiraterone—Myalgia—Progesterone—uterine cancer	0.000334	0.00497	CcSEcCtD
Abiraterone—Chest pain—Progesterone—uterine cancer	0.000334	0.00497	CcSEcCtD
Abiraterone—Unspecified disorder of skin and subcutaneous tissue—Progesterone—uterine cancer	0.000332	0.00494	CcSEcCtD
Abiraterone—ABCC1—uterus—uterine cancer	0.000332	0.0277	CbGeAlD
Abiraterone—Discomfort—Progesterone—uterine cancer	0.00033	0.00491	CcSEcCtD
Abiraterone—Anaemia—Medroxyprogesterone Acetate—uterine cancer	0.000329	0.00489	CcSEcCtD
Abiraterone—Oedema—Progesterone—uterine cancer	0.000321	0.00476	CcSEcCtD
Abiraterone—Infection—Progesterone—uterine cancer	0.000319	0.00473	CcSEcCtD
Abiraterone—CYP2C8—renal system—uterine cancer	0.000317	0.0264	CbGeAlD
Abiraterone—Skin disorder—Progesterone—uterine cancer	0.000311	0.00463	CcSEcCtD
Abiraterone—CYP2C8—endometrium—uterine cancer	0.000307	0.0256	CbGeAlD
Abiraterone—Myalgia—Medroxyprogesterone Acetate—uterine cancer	0.000303	0.0045	CcSEcCtD
Abiraterone—Chest pain—Medroxyprogesterone Acetate—uterine cancer	0.000303	0.0045	CcSEcCtD
Abiraterone—Unspecified disorder of skin and subcutaneous tissue—Medroxyprogesterone Acetate—uterine cancer	0.000301	0.00447	CcSEcCtD
Abiraterone—Discomfort—Medroxyprogesterone Acetate—uterine cancer	0.000299	0.00445	CcSEcCtD
Abiraterone—Alanine aminotransferase increased—Etoposide—uterine cancer	0.000294	0.00437	CcSEcCtD
Abiraterone—Musculoskeletal discomfort—Progesterone—uterine cancer	0.000292	0.00434	CcSEcCtD
Abiraterone—Oedema—Medroxyprogesterone Acetate—uterine cancer	0.000291	0.00432	CcSEcCtD
Abiraterone—Insomnia—Progesterone—uterine cancer	0.00029	0.00431	CcSEcCtD
Abiraterone—Infection—Medroxyprogesterone Acetate—uterine cancer	0.000289	0.00429	CcSEcCtD
Abiraterone—Dyspnoea—Progesterone—uterine cancer	0.000286	0.00425	CcSEcCtD
Abiraterone—Dyspepsia—Progesterone—uterine cancer	0.000282	0.00419	CcSEcCtD
Abiraterone—Skin disorder—Medroxyprogesterone Acetate—uterine cancer	0.000282	0.00419	CcSEcCtD
Abiraterone—Nocturia—Epirubicin—uterine cancer	0.000278	0.00413	CcSEcCtD
Abiraterone—Gastrointestinal disorder—Progesterone—uterine cancer	0.000277	0.00411	CcSEcCtD
Abiraterone—Fatigue—Progesterone—uterine cancer	0.000276	0.00411	CcSEcCtD
Abiraterone—Constipation—Progesterone—uterine cancer	0.000274	0.00407	CcSEcCtD
Abiraterone—ABCC1—female gonad—uterine cancer	0.000271	0.0226	CbGeAlD
Abiraterone—ABCC1—vagina—uterine cancer	0.00027	0.0225	CbGeAlD
Abiraterone—Musculoskeletal discomfort—Medroxyprogesterone Acetate—uterine cancer	0.000265	0.00393	CcSEcCtD
Abiraterone—Insomnia—Medroxyprogesterone Acetate—uterine cancer	0.000263	0.0039	CcSEcCtD
Abiraterone—Dyspnoea—Medroxyprogesterone Acetate—uterine cancer	0.000259	0.00385	CcSEcCtD
Abiraterone—Pneumonia—Etoposide—uterine cancer	0.000259	0.00384	CcSEcCtD
Abiraterone—Phosphatase alkaline increased—Epirubicin—uterine cancer	0.000258	0.00383	CcSEcCtD
Abiraterone—Infestation—Etoposide—uterine cancer	0.000257	0.00382	CcSEcCtD
Abiraterone—Infestation NOS—Etoposide—uterine cancer	0.000257	0.00382	CcSEcCtD
Abiraterone—Nocturia—Doxorubicin—uterine cancer	0.000257	0.00382	CcSEcCtD
Abiraterone—Anaemia—Dactinomycin—uterine cancer	0.000257	0.00381	CcSEcCtD
Abiraterone—Dyspepsia—Medroxyprogesterone Acetate—uterine cancer	0.000256	0.0038	CcSEcCtD
Abiraterone—CYP2C8—female reproductive system—uterine cancer	0.000254	0.0212	CbGeAlD
Abiraterone—Acute coronary syndrome—Etoposide—uterine cancer	0.000254	0.00377	CcSEcCtD
Abiraterone—Body temperature increased—Progesterone—uterine cancer	0.000253	0.00377	CcSEcCtD
Abiraterone—Myocardial infarction—Etoposide—uterine cancer	0.000252	0.00375	CcSEcCtD
Abiraterone—Gastrointestinal disorder—Medroxyprogesterone Acetate—uterine cancer	0.000251	0.00373	CcSEcCtD
Abiraterone—Fatigue—Medroxyprogesterone Acetate—uterine cancer	0.00025	0.00372	CcSEcCtD
Abiraterone—Constipation—Medroxyprogesterone Acetate—uterine cancer	0.000248	0.00369	CcSEcCtD
Abiraterone—Fluid retention—Epirubicin—uterine cancer	0.000245	0.00364	CcSEcCtD
Abiraterone—ORM1—lymph node—uterine cancer	0.000241	0.0201	CbGeAlD
Abiraterone—Phosphatase alkaline increased—Doxorubicin—uterine cancer	0.000238	0.00354	CcSEcCtD
Abiraterone—Myalgia—Dactinomycin—uterine cancer	0.000236	0.00351	CcSEcCtD
Abiraterone—Discomfort—Dactinomycin—uterine cancer	0.000234	0.00347	CcSEcCtD
Abiraterone—Asthenia—Progesterone—uterine cancer	0.00023	0.00342	CcSEcCtD
Abiraterone—CYP2C8—vagina—uterine cancer	0.00023	0.0191	CbGeAlD
Abiraterone—Body temperature increased—Medroxyprogesterone Acetate—uterine cancer	0.00023	0.00341	CcSEcCtD
Abiraterone—Urinary tract disorder—Etoposide—uterine cancer	0.000228	0.00339	CcSEcCtD
Abiraterone—Oedema—Dactinomycin—uterine cancer	0.000227	0.00337	CcSEcCtD
Abiraterone—Fluid retention—Doxorubicin—uterine cancer	0.000226	0.00336	CcSEcCtD
Abiraterone—Urethral disorder—Etoposide—uterine cancer	0.000226	0.00336	CcSEcCtD
Abiraterone—Infection—Dactinomycin—uterine cancer	0.000225	0.00335	CcSEcCtD
Abiraterone—Diarrhoea—Progesterone—uterine cancer	0.000219	0.00326	CcSEcCtD
Abiraterone—Blood alkaline phosphatase increased—Epirubicin—uterine cancer	0.000215	0.0032	CcSEcCtD
Abiraterone—CYP3A4—renal system—uterine cancer	0.000215	0.0179	CbGeAlD
Abiraterone—Cardiac disorder—Etoposide—uterine cancer	0.000214	0.00318	CcSEcCtD
Abiraterone—ALB—lymph node—uterine cancer	0.000211	0.0176	CbGeAlD
Abiraterone—CYP2D6—renal system—uterine cancer	0.000211	0.0176	CbGeAlD
Abiraterone—Angiopathy—Etoposide—uterine cancer	0.000209	0.00311	CcSEcCtD
Abiraterone—Asthenia—Medroxyprogesterone Acetate—uterine cancer	0.000208	0.0031	CcSEcCtD
Abiraterone—Mediastinal disorder—Etoposide—uterine cancer	0.000208	0.00309	CcSEcCtD
Abiraterone—Musculoskeletal discomfort—Dactinomycin—uterine cancer	0.000206	0.00307	CcSEcCtD
Abiraterone—Vomiting—Progesterone—uterine cancer	0.000204	0.00303	CcSEcCtD
Abiraterone—Rash—Progesterone—uterine cancer	0.000202	0.003	CcSEcCtD
Abiraterone—Dermatitis—Progesterone—uterine cancer	0.000202	0.003	CcSEcCtD
Abiraterone—Hot flush—Epirubicin—uterine cancer	0.0002	0.00297	CcSEcCtD
Abiraterone—Blood alkaline phosphatase increased—Doxorubicin—uterine cancer	0.000199	0.00296	CcSEcCtD
Abiraterone—Diarrhoea—Medroxyprogesterone Acetate—uterine cancer	0.000199	0.00295	CcSEcCtD
Abiraterone—Menopausal symptoms—Epirubicin—uterine cancer	0.000198	0.00295	CcSEcCtD
Abiraterone—Fatigue—Dactinomycin—uterine cancer	0.000195	0.0029	CcSEcCtD
Abiraterone—Cardiac failure—Epirubicin—uterine cancer	0.000192	0.00285	CcSEcCtD
Abiraterone—Anaemia—Etoposide—uterine cancer	0.000186	0.00276	CcSEcCtD
Abiraterone—Hot flush—Doxorubicin—uterine cancer	0.000185	0.00275	CcSEcCtD
Abiraterone—Vomiting—Medroxyprogesterone Acetate—uterine cancer	0.000185	0.00274	CcSEcCtD
Abiraterone—Menopausal symptoms—Doxorubicin—uterine cancer	0.000183	0.00273	CcSEcCtD
Abiraterone—Rash—Medroxyprogesterone Acetate—uterine cancer	0.000183	0.00272	CcSEcCtD
Abiraterone—Dermatitis—Medroxyprogesterone Acetate—uterine cancer	0.000183	0.00272	CcSEcCtD
Abiraterone—Body temperature increased—Dactinomycin—uterine cancer	0.000179	0.00266	CcSEcCtD
Abiraterone—Cardiac failure—Doxorubicin—uterine cancer	0.000177	0.00264	CcSEcCtD
Abiraterone—Cough—Etoposide—uterine cancer	0.000175	0.00261	CcSEcCtD
Abiraterone—ABCC1—lymph node—uterine cancer	0.000175	0.0145	CbGeAlD
Abiraterone—Hypertension—Etoposide—uterine cancer	0.000174	0.00258	CcSEcCtD
Abiraterone—CYP3A4—female reproductive system—uterine cancer	0.000172	0.0143	CbGeAlD
Abiraterone—Chest pain—Etoposide—uterine cancer	0.000171	0.00254	CcSEcCtD
Abiraterone—Hypokalaemia—Epirubicin—uterine cancer	0.00017	0.00253	CcSEcCtD
Abiraterone—Unspecified disorder of skin and subcutaneous tissue—Etoposide—uterine cancer	0.00017	0.00252	CcSEcCtD
Abiraterone—CYP2D6—female reproductive system—uterine cancer	0.000169	0.0141	CbGeAlD
Abiraterone—Discomfort—Etoposide—uterine cancer	0.000169	0.00251	CcSEcCtD
Abiraterone—Aspartate aminotransferase increased—Epirubicin—uterine cancer	0.000168	0.0025	CcSEcCtD
Abiraterone—Nasopharyngitis—Epirubicin—uterine cancer	0.000167	0.00249	CcSEcCtD
Abiraterone—Alanine aminotransferase increased—Epirubicin—uterine cancer	0.000165	0.00245	CcSEcCtD
Abiraterone—Infection—Etoposide—uterine cancer	0.000163	0.00242	CcSEcCtD
Abiraterone—Asthenia—Dactinomycin—uterine cancer	0.000163	0.00242	CcSEcCtD
Abiraterone—Skin disorder—Etoposide—uterine cancer	0.000159	0.00237	CcSEcCtD
Abiraterone—Hypokalaemia—Doxorubicin—uterine cancer	0.000158	0.00234	CcSEcCtD
Abiraterone—Aspartate aminotransferase increased—Doxorubicin—uterine cancer	0.000156	0.00232	CcSEcCtD
Abiraterone—Diarrhoea—Dactinomycin—uterine cancer	0.000155	0.0023	CcSEcCtD
Abiraterone—Nasopharyngitis—Doxorubicin—uterine cancer	0.000155	0.0023	CcSEcCtD
Abiraterone—CYP2D6—female gonad—uterine cancer	0.000154	0.0128	CbGeAlD
Abiraterone—Alanine aminotransferase increased—Doxorubicin—uterine cancer	0.000153	0.00227	CcSEcCtD
Abiraterone—Upper respiratory tract infection—Epirubicin—uterine cancer	0.00015	0.00223	CcSEcCtD
Abiraterone—Pollakiuria—Epirubicin—uterine cancer	0.000149	0.00222	CcSEcCtD
Abiraterone—Dyspnoea—Etoposide—uterine cancer	0.000146	0.00217	CcSEcCtD
Abiraterone—Hyperglycaemia—Epirubicin—uterine cancer	0.000146	0.00217	CcSEcCtD
Abiraterone—Pneumonia—Epirubicin—uterine cancer	0.000145	0.00215	CcSEcCtD
Abiraterone—Infestation NOS—Epirubicin—uterine cancer	0.000144	0.00214	CcSEcCtD
Abiraterone—Infestation—Epirubicin—uterine cancer	0.000144	0.00214	CcSEcCtD
Abiraterone—Vomiting—Dactinomycin—uterine cancer	0.000144	0.00214	CcSEcCtD
Abiraterone—Rash—Dactinomycin—uterine cancer	0.000143	0.00212	CcSEcCtD
Abiraterone—Gastrointestinal disorder—Etoposide—uterine cancer	0.000142	0.0021	CcSEcCtD
Abiraterone—Fatigue—Etoposide—uterine cancer	0.000141	0.0021	CcSEcCtD
Abiraterone—Constipation—Etoposide—uterine cancer	0.00014	0.00208	CcSEcCtD
Abiraterone—Urinary tract infection—Epirubicin—uterine cancer	0.00014	0.00208	CcSEcCtD
Abiraterone—Upper respiratory tract infection—Doxorubicin—uterine cancer	0.000139	0.00207	CcSEcCtD
Abiraterone—Pollakiuria—Doxorubicin—uterine cancer	0.000138	0.00205	CcSEcCtD
Abiraterone—Haematuria—Epirubicin—uterine cancer	0.000137	0.00204	CcSEcCtD
Abiraterone—Hyperglycaemia—Doxorubicin—uterine cancer	0.000135	0.00201	CcSEcCtD
Abiraterone—Pneumonia—Doxorubicin—uterine cancer	0.000134	0.00199	CcSEcCtD
Abiraterone—Infestation—Doxorubicin—uterine cancer	0.000133	0.00198	CcSEcCtD
Abiraterone—Infestation NOS—Doxorubicin—uterine cancer	0.000133	0.00198	CcSEcCtD
Abiraterone—Body temperature increased—Etoposide—uterine cancer	0.00013	0.00193	CcSEcCtD
Abiraterone—Urinary tract infection—Doxorubicin—uterine cancer	0.00013	0.00193	CcSEcCtD
Abiraterone—Urinary tract disorder—Epirubicin—uterine cancer	0.000128	0.0019	CcSEcCtD
Abiraterone—Haematuria—Doxorubicin—uterine cancer	0.000127	0.00189	CcSEcCtD
Abiraterone—Connective tissue disorder—Epirubicin—uterine cancer	0.000127	0.00189	CcSEcCtD
Abiraterone—Urethral disorder—Epirubicin—uterine cancer	0.000127	0.00188	CcSEcCtD
Abiraterone—CYP2C8—Phase 1 - Functionalization of compounds—CYP11A1—uterine cancer	0.000123	0.00248	CbGpPWpGaD
Abiraterone—CYP2D6—Oxidation by Cytochrome P450—CYP11A1—uterine cancer	0.000123	0.00248	CbGpPWpGaD
Abiraterone—Cardiac disorder—Epirubicin—uterine cancer	0.00012	0.00178	CcSEcCtD
Abiraterone—ALB—Selenium Micronutrient Network—GPX3—uterine cancer	0.00012	0.00241	CbGpPWpGaD
Abiraterone—Urinary tract disorder—Doxorubicin—uterine cancer	0.000118	0.00176	CcSEcCtD
Abiraterone—Asthenia—Etoposide—uterine cancer	0.000118	0.00175	CcSEcCtD
Abiraterone—Connective tissue disorder—Doxorubicin—uterine cancer	0.000118	0.00175	CcSEcCtD
Abiraterone—Angiopathy—Epirubicin—uterine cancer	0.000117	0.00174	CcSEcCtD
Abiraterone—Urethral disorder—Doxorubicin—uterine cancer	0.000117	0.00174	CcSEcCtD
Abiraterone—Mediastinal disorder—Epirubicin—uterine cancer	0.000117	0.00173	CcSEcCtD
Abiraterone—CYP2C8—Metapathway biotransformation—AKR1B10—uterine cancer	0.000116	0.00234	CbGpPWpGaD
Abiraterone—Arrhythmia—Epirubicin—uterine cancer	0.000116	0.00172	CcSEcCtD
Abiraterone—ABCC1—Defective AMN causes hereditary megaloblastic anemia 1—MTHFR—uterine cancer	0.000114	0.0023	CbGpPWpGaD
Abiraterone—Mental disorder—Epirubicin—uterine cancer	0.000113	0.00168	CcSEcCtD
Abiraterone—Diarrhoea—Etoposide—uterine cancer	0.000112	0.00167	CcSEcCtD
Abiraterone—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP19A1—uterine cancer	0.000112	0.00225	CbGpPWpGaD
Abiraterone—Cardiac disorder—Doxorubicin—uterine cancer	0.000111	0.00165	CcSEcCtD
Abiraterone—CYP2C8—Oxidation by Cytochrome P450—CYP19A1—uterine cancer	0.00011	0.00222	CbGpPWpGaD
Abiraterone—SULT2A1—Corticotropin-releasing hormone—AKT1—uterine cancer	0.00011	0.0022	CbGpPWpGaD
Abiraterone—Angiopathy—Doxorubicin—uterine cancer	0.000109	0.00161	CcSEcCtD
Abiraterone—Mediastinal disorder—Doxorubicin—uterine cancer	0.000108	0.0016	CcSEcCtD
Abiraterone—CYP2C8—Metapathway biotransformation—AKR1B1—uterine cancer	0.000108	0.00217	CbGpPWpGaD
Abiraterone—SULT2A1—Metabolism—AKR1B1—uterine cancer	0.000107	0.00216	CbGpPWpGaD
Abiraterone—SULT2A1—Metabolism—STAR—uterine cancer	0.000107	0.00216	CbGpPWpGaD
Abiraterone—Arrhythmia—Doxorubicin—uterine cancer	0.000107	0.00159	CcSEcCtD
Abiraterone—ABCC1—Metabolism of lipids and lipoproteins—SRD5A2—uterine cancer	0.000106	0.00214	CbGpPWpGaD
Abiraterone—SULT2A1—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—uterine cancer	0.000106	0.00213	CbGpPWpGaD
Abiraterone—SULT2A1—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	0.000106	0.00213	CbGpPWpGaD
Abiraterone—Mental disorder—Doxorubicin—uterine cancer	0.000105	0.00156	CcSEcCtD
Abiraterone—Vomiting—Etoposide—uterine cancer	0.000104	0.00155	CcSEcCtD
Abiraterone—Anaemia—Epirubicin—uterine cancer	0.000104	0.00155	CcSEcCtD
Abiraterone—Rash—Etoposide—uterine cancer	0.000103	0.00154	CcSEcCtD
Abiraterone—Dermatitis—Etoposide—uterine cancer	0.000103	0.00154	CcSEcCtD
Abiraterone—CYP2D6—Phase 1 - Functionalization of compounds—CYP11A1—uterine cancer	0.000101	0.00204	CbGpPWpGaD
Abiraterone—Cough—Epirubicin—uterine cancer	9.83e-05	0.00146	CcSEcCtD
Abiraterone—Hypertension—Epirubicin—uterine cancer	9.73e-05	0.00145	CcSEcCtD
Abiraterone—Anaemia—Doxorubicin—uterine cancer	9.63e-05	0.00143	CcSEcCtD
Abiraterone—Myalgia—Epirubicin—uterine cancer	9.59e-05	0.00143	CcSEcCtD
Abiraterone—Chest pain—Epirubicin—uterine cancer	9.59e-05	0.00143	CcSEcCtD
Abiraterone—CYP2D6—Metapathway biotransformation—AKR1B10—uterine cancer	9.53e-05	0.00192	CbGpPWpGaD
Abiraterone—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—uterine cancer	9.52e-05	0.00142	CcSEcCtD
Abiraterone—ALB—Vitamin B12 Metabolism—MTHFR—uterine cancer	9.52e-05	0.00192	CbGpPWpGaD
Abiraterone—Discomfort—Epirubicin—uterine cancer	9.48e-05	0.00141	CcSEcCtD
Abiraterone—CYP17A1—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	9.36e-05	0.00188	CbGpPWpGaD
Abiraterone—Oedema—Epirubicin—uterine cancer	9.19e-05	0.00137	CcSEcCtD
Abiraterone—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP19A1—uterine cancer	9.18e-05	0.00185	CbGpPWpGaD
Abiraterone—Infection—Epirubicin—uterine cancer	9.13e-05	0.00136	CcSEcCtD
Abiraterone—Cough—Doxorubicin—uterine cancer	9.1e-05	0.00135	CcSEcCtD
Abiraterone—CYP2C8—Phase 1 - Functionalization of compounds—CYP19A1—uterine cancer	9.07e-05	0.00183	CbGpPWpGaD
Abiraterone—CYP2D6—Oxidation by Cytochrome P450—CYP19A1—uterine cancer	9.06e-05	0.00182	CbGpPWpGaD
Abiraterone—Hypertension—Doxorubicin—uterine cancer	9e-05	0.00134	CcSEcCtD
Abiraterone—Skin disorder—Epirubicin—uterine cancer	8.93e-05	0.00133	CcSEcCtD
Abiraterone—Chest pain—Doxorubicin—uterine cancer	8.87e-05	0.00132	CcSEcCtD
Abiraterone—Myalgia—Doxorubicin—uterine cancer	8.87e-05	0.00132	CcSEcCtD
Abiraterone—CYP2D6—Metapathway biotransformation—AKR1B1—uterine cancer	8.86e-05	0.00178	CbGpPWpGaD
Abiraterone—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—uterine cancer	8.81e-05	0.00131	CcSEcCtD
Abiraterone—Discomfort—Doxorubicin—uterine cancer	8.77e-05	0.0013	CcSEcCtD
Abiraterone—Oedema—Doxorubicin—uterine cancer	8.51e-05	0.00126	CcSEcCtD
Abiraterone—Infection—Doxorubicin—uterine cancer	8.45e-05	0.00126	CcSEcCtD
Abiraterone—SULT2A1—Metabolism—POLD1—uterine cancer	8.4e-05	0.00169	CbGpPWpGaD
Abiraterone—Musculoskeletal discomfort—Epirubicin—uterine cancer	8.38e-05	0.00124	CcSEcCtD
Abiraterone—Insomnia—Epirubicin—uterine cancer	8.32e-05	0.00124	CcSEcCtD
Abiraterone—Skin disorder—Doxorubicin—uterine cancer	8.26e-05	0.00123	CcSEcCtD
Abiraterone—Dyspnoea—Epirubicin—uterine cancer	8.2e-05	0.00122	CcSEcCtD
Abiraterone—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP11A1—uterine cancer	8.16e-05	0.00164	CbGpPWpGaD
Abiraterone—Dyspepsia—Epirubicin—uterine cancer	8.09e-05	0.0012	CcSEcCtD
Abiraterone—CYP3A4—Oxidation by Cytochrome P450—CYP11A1—uterine cancer	8.05e-05	0.00162	CbGpPWpGaD
Abiraterone—Gastrointestinal disorder—Epirubicin—uterine cancer	7.94e-05	0.00118	CcSEcCtD
Abiraterone—Fatigue—Epirubicin—uterine cancer	7.93e-05	0.00118	CcSEcCtD
Abiraterone—CYP2C8—Metapathway biotransformation—AKR1C1—uterine cancer	7.92e-05	0.00159	CbGpPWpGaD
Abiraterone—Constipation—Epirubicin—uterine cancer	7.86e-05	0.00117	CcSEcCtD
Abiraterone—CYP17A1—Metabolism—SRD5A2—uterine cancer	7.86e-05	0.00158	CbGpPWpGaD
Abiraterone—CYP17A1—Metabolism—NDUFB11—uterine cancer	7.86e-05	0.00158	CbGpPWpGaD
Abiraterone—SULT2A1—Metabolism—AKR1C1—uterine cancer	7.86e-05	0.00158	CbGpPWpGaD
Abiraterone—Musculoskeletal discomfort—Doxorubicin—uterine cancer	7.75e-05	0.00115	CcSEcCtD
Abiraterone—ALB—Folate Metabolism—MTHFR—uterine cancer	7.74e-05	0.00156	CbGpPWpGaD
Abiraterone—Insomnia—Doxorubicin—uterine cancer	7.69e-05	0.00114	CcSEcCtD
Abiraterone—ABCC1—Metabolism of lipids and lipoproteins—STAR—uterine cancer	7.69e-05	0.00155	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism of lipids and lipoproteins—AKR1B1—uterine cancer	7.69e-05	0.00155	CbGpPWpGaD
Abiraterone—CYP17A1—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	7.63e-05	0.00154	CbGpPWpGaD
Abiraterone—Dyspnoea—Doxorubicin—uterine cancer	7.58e-05	0.00113	CcSEcCtD
Abiraterone—Dyspepsia—Doxorubicin—uterine cancer	7.49e-05	0.00111	CcSEcCtD
Abiraterone—ALB—Vitamin B12 Metabolism—CCL2—uterine cancer	7.45e-05	0.0015	CbGpPWpGaD
Abiraterone—CYP2D6—Phase 1 - Functionalization of compounds—CYP19A1—uterine cancer	7.44e-05	0.0015	CbGpPWpGaD
Abiraterone—CYP3A4—Tryptophan metabolism—CYP19A1—uterine cancer	7.43e-05	0.00149	CbGpPWpGaD
Abiraterone—Gastrointestinal disorder—Doxorubicin—uterine cancer	7.34e-05	0.00109	CcSEcCtD
Abiraterone—Fatigue—Doxorubicin—uterine cancer	7.33e-05	0.00109	CcSEcCtD
Abiraterone—ABCC1—Transmembrane transport of small molecules—ABCC9—uterine cancer	7.32e-05	0.00147	CbGpPWpGaD
Abiraterone—Constipation—Doxorubicin—uterine cancer	7.27e-05	0.00108	CcSEcCtD
Abiraterone—Body temperature increased—Epirubicin—uterine cancer	7.27e-05	0.00108	CcSEcCtD
Abiraterone—CYP17A1—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	7.21e-05	0.00145	CbGpPWpGaD
Abiraterone—SULT2A1—Metabolism—RRM2—uterine cancer	7e-05	0.00141	CbGpPWpGaD
Abiraterone—CYP2C8—Metapathway biotransformation—GPX3—uterine cancer	6.95e-05	0.0014	CbGpPWpGaD
Abiraterone—SULT2A1—Metabolism—DCN—uterine cancer	6.8e-05	0.00137	CbGpPWpGaD
Abiraterone—Body temperature increased—Doxorubicin—uterine cancer	6.72e-05	0.000999	CcSEcCtD
Abiraterone—CYP3A4—Phase 1 - Functionalization of compounds—CYP11A1—uterine cancer	6.61e-05	0.00133	CbGpPWpGaD
Abiraterone—Asthenia—Epirubicin—uterine cancer	6.6e-05	0.00098	CcSEcCtD
Abiraterone—CYP2C8—Biological oxidations—CYP11A1—uterine cancer	6.55e-05	0.00132	CbGpPWpGaD
Abiraterone—CYP2D6—Metapathway biotransformation—AKR1C1—uterine cancer	6.5e-05	0.00131	CbGpPWpGaD
Abiraterone—CYP2C8—Metapathway biotransformation—CYP11A1—uterine cancer	6.46e-05	0.0013	CbGpPWpGaD
Abiraterone—SULT2A1—Metabolism—CYP11A1—uterine cancer	6.4e-05	0.00129	CbGpPWpGaD
Abiraterone—Diarrhoea—Epirubicin—uterine cancer	6.29e-05	0.000935	CcSEcCtD
Abiraterone—CYP3A4—Metapathway biotransformation—AKR1B10—uterine cancer	6.23e-05	0.00125	CbGpPWpGaD
Abiraterone—ALB—Selenium Micronutrient Network—MTHFR—uterine cancer	6.15e-05	0.00124	CbGpPWpGaD
Abiraterone—Asthenia—Doxorubicin—uterine cancer	6.1e-05	0.000907	CcSEcCtD
Abiraterone—CYP2C8—Metapathway biotransformation—AKR1C3—uterine cancer	6.1e-05	0.00123	CbGpPWpGaD
Abiraterone—ALB—Folate Metabolism—CCL2—uterine cancer	6.06e-05	0.00122	CbGpPWpGaD
Abiraterone—SULT2A1—Metabolism—AKR1C3—uterine cancer	6.05e-05	0.00122	CbGpPWpGaD
Abiraterone—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—uterine cancer	6e-05	0.00121	CbGpPWpGaD
Abiraterone—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—uterine cancer	5.92e-05	0.00119	CbGpPWpGaD
Abiraterone—Vomiting—Epirubicin—uterine cancer	5.85e-05	0.000869	CcSEcCtD
Abiraterone—Diarrhoea—Doxorubicin—uterine cancer	5.82e-05	0.000865	CcSEcCtD
Abiraterone—CYP2C8—Metabolism of lipids and lipoproteins—SRD5A2—uterine cancer	5.81e-05	0.00117	CbGpPWpGaD
Abiraterone—Rash—Epirubicin—uterine cancer	5.8e-05	0.000861	CcSEcCtD
Abiraterone—CYP3A4—Metapathway biotransformation—AKR1B1—uterine cancer	5.79e-05	0.00117	CbGpPWpGaD
Abiraterone—Dermatitis—Epirubicin—uterine cancer	5.79e-05	0.000861	CcSEcCtD
Abiraterone—ALB—Metabolism of lipids and lipoproteins—SRD5A2—uterine cancer	5.78e-05	0.00116	CbGpPWpGaD
Abiraterone—CYP2D6—Metapathway biotransformation—GPX3—uterine cancer	5.71e-05	0.00115	CbGpPWpGaD
Abiraterone—CYP17A1—Metabolism—AKR1B1—uterine cancer	5.68e-05	0.00114	CbGpPWpGaD
Abiraterone—CYP17A1—Metabolism—STAR—uterine cancer	5.68e-05	0.00114	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	5.65e-05	0.00114	CbGpPWpGaD
Abiraterone—CYP17A1—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	5.61e-05	0.00113	CbGpPWpGaD
Abiraterone—Vomiting—Doxorubicin—uterine cancer	5.41e-05	0.000804	CcSEcCtD
Abiraterone—CYP2D6—Biological oxidations—CYP11A1—uterine cancer	5.37e-05	0.00108	CbGpPWpGaD
Abiraterone—Rash—Doxorubicin—uterine cancer	5.36e-05	0.000797	CcSEcCtD
Abiraterone—Dermatitis—Doxorubicin—uterine cancer	5.36e-05	0.000796	CcSEcCtD
Abiraterone—CYP2D6—Metapathway biotransformation—CYP11A1—uterine cancer	5.3e-05	0.00107	CbGpPWpGaD
Abiraterone—CYP2D6—Metapathway biotransformation—AKR1C3—uterine cancer	5.01e-05	0.00101	CbGpPWpGaD
Abiraterone—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—uterine cancer	4.87e-05	0.00098	CbGpPWpGaD
Abiraterone—CYP2C8—Biological oxidations—CYP19A1—uterine cancer	4.82e-05	0.00097	CbGpPWpGaD
Abiraterone—ALB—Selenium Micronutrient Network—CCL2—uterine cancer	4.81e-05	0.000969	CbGpPWpGaD
Abiraterone—CYP2C8—Metapathway biotransformation—CYP19A1—uterine cancer	4.75e-05	0.000956	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism—NDUFB11—uterine cancer	4.74e-05	0.000954	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism—SRD5A2—uterine cancer	4.74e-05	0.000954	CbGpPWpGaD
Abiraterone—SULT2A1—Metabolism—STK11—uterine cancer	4.71e-05	0.000949	CbGpPWpGaD
Abiraterone—SULT2A1—Metabolism—CYP19A1—uterine cancer	4.71e-05	0.000949	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	4.6e-05	0.000927	CbGpPWpGaD
Abiraterone—CYP17A1—Metabolism—POLD1—uterine cancer	4.46e-05	0.000897	CbGpPWpGaD
Abiraterone—SULT2A1—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	4.42e-05	0.000891	CbGpPWpGaD
Abiraterone—ABCC1—Disease—AKR1B10—uterine cancer	4.4e-05	0.000886	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	4.35e-05	0.000875	CbGpPWpGaD
Abiraterone—CYP3A4—Metapathway biotransformation—AKR1C1—uterine cancer	4.25e-05	0.000856	CbGpPWpGaD
Abiraterone—SULT2A1—Metabolism of lipids and lipoproteins—EP300—uterine cancer	4.22e-05	0.000849	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism of lipids and lipoproteins—STAR—uterine cancer	4.2e-05	0.000846	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism of lipids and lipoproteins—AKR1B1—uterine cancer	4.2e-05	0.000846	CbGpPWpGaD
Abiraterone—ALB—Metabolism of lipids and lipoproteins—AKR1B1—uterine cancer	4.18e-05	0.000841	CbGpPWpGaD
Abiraterone—ALB—Metabolism of lipids and lipoproteins—STAR—uterine cancer	4.18e-05	0.000841	CbGpPWpGaD
Abiraterone—CYP17A1—Metabolism—AKR1C1—uterine cancer	4.17e-05	0.000839	CbGpPWpGaD
Abiraterone—ALB—Transmembrane transport of small molecules—ABCC9—uterine cancer	3.97e-05	0.0008	CbGpPWpGaD
Abiraterone—CYP2D6—Biological oxidations—CYP19A1—uterine cancer	3.95e-05	0.000796	CbGpPWpGaD
Abiraterone—CYP2D6—Metapathway biotransformation—CYP19A1—uterine cancer	3.9e-05	0.000785	CbGpPWpGaD
Abiraterone—CYP3A4—Metapathway biotransformation—GPX3—uterine cancer	3.73e-05	0.000751	CbGpPWpGaD
Abiraterone—CYP17A1—Metabolism—RRM2—uterine cancer	3.72e-05	0.000748	CbGpPWpGaD
Abiraterone—ABCC1—Disease—RNF43—uterine cancer	3.65e-05	0.000734	CbGpPWpGaD
Abiraterone—CYP17A1—Metabolism—DCN—uterine cancer	3.61e-05	0.000726	CbGpPWpGaD
Abiraterone—SULT2A1—Metabolism—MTHFR—uterine cancer	3.54e-05	0.000713	CbGpPWpGaD
Abiraterone—CYP3A4—Biological oxidations—CYP11A1—uterine cancer	3.51e-05	0.000707	CbGpPWpGaD
Abiraterone—CYP3A4—Metapathway biotransformation—CYP11A1—uterine cancer	3.47e-05	0.000698	CbGpPWpGaD
Abiraterone—ALB—FOXA2 and FOXA3 transcription factor networks—AKT1—uterine cancer	3.43e-05	0.000691	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism—STAR—uterine cancer	3.43e-05	0.00069	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism—AKR1B1—uterine cancer	3.43e-05	0.00069	CbGpPWpGaD
Abiraterone—CYP17A1—Metabolism—CYP11A1—uterine cancer	3.4e-05	0.000684	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	3.39e-05	0.000682	CbGpPWpGaD
Abiraterone—ALB—Platelet degranulation—VEGFA—uterine cancer	3.34e-05	0.000672	CbGpPWpGaD
Abiraterone—CYP3A4—Metapathway biotransformation—AKR1C3—uterine cancer	3.27e-05	0.000659	CbGpPWpGaD
Abiraterone—CYP17A1—Metabolism—AKR1C3—uterine cancer	3.21e-05	0.000646	CbGpPWpGaD
Abiraterone—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—uterine cancer	3.18e-05	0.00064	CbGpPWpGaD
Abiraterone—SULT2A1—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	3.12e-05	0.000628	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	3.08e-05	0.000621	CbGpPWpGaD
Abiraterone—ALB—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	3.07e-05	0.000617	CbGpPWpGaD
Abiraterone—ABCC1—Disease—AKR1C1—uterine cancer	3e-05	0.000605	CbGpPWpGaD
Abiraterone—ALB—Folate Metabolism—TP53—uterine cancer	2.94e-05	0.000592	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism—POLD1—uterine cancer	2.69e-05	0.000541	CbGpPWpGaD
Abiraterone—ABCC1—Disease—DCN—uterine cancer	2.6e-05	0.000523	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—SRD5A2—uterine cancer	2.59e-05	0.000521	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—NDUFB11—uterine cancer	2.59e-05	0.000521	CbGpPWpGaD
Abiraterone—CYP3A4—Biological oxidations—CYP19A1—uterine cancer	2.59e-05	0.00052	CbGpPWpGaD
Abiraterone—ALB—Hemostasis—IRF1—uterine cancer	2.58e-05	0.000519	CbGpPWpGaD
Abiraterone—ALB—Metabolism—SRD5A2—uterine cancer	2.57e-05	0.000518	CbGpPWpGaD
Abiraterone—ALB—Metabolism—NDUFB11—uterine cancer	2.57e-05	0.000518	CbGpPWpGaD
Abiraterone—CYP3A4—Metapathway biotransformation—CYP19A1—uterine cancer	2.55e-05	0.000513	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism—AKR1C1—uterine cancer	2.51e-05	0.000506	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	2.51e-05	0.000506	CbGpPWpGaD
Abiraterone—CYP17A1—Metabolism—CYP19A1—uterine cancer	2.5e-05	0.000503	CbGpPWpGaD
Abiraterone—CYP17A1—Metabolism—STK11—uterine cancer	2.5e-05	0.000503	CbGpPWpGaD
Abiraterone—ALB—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	2.5e-05	0.000503	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	2.37e-05	0.000478	CbGpPWpGaD
Abiraterone—ALB—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	2.36e-05	0.000475	CbGpPWpGaD
Abiraterone—CYP17A1—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	2.35e-05	0.000473	CbGpPWpGaD
Abiraterone—ABCC1—Disease—AKR1C3—uterine cancer	2.31e-05	0.000465	CbGpPWpGaD
Abiraterone—ABCC1—Disease—HMGA1—uterine cancer	2.25e-05	0.000454	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism—RRM2—uterine cancer	2.24e-05	0.000451	CbGpPWpGaD
Abiraterone—CYP17A1—Metabolism of lipids and lipoproteins—EP300—uterine cancer	2.24e-05	0.000451	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism—DCN—uterine cancer	2.18e-05	0.000438	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—SRD5A2—uterine cancer	2.12e-05	0.000428	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—NDUFB11—uterine cancer	2.12e-05	0.000428	CbGpPWpGaD
Abiraterone—ABCC1—Disease—FBXW7—uterine cancer	2.06e-05	0.000415	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism—CYP11A1—uterine cancer	2.05e-05	0.000413	CbGpPWpGaD
Abiraterone—SULT2A1—Metabolism—PTEN—uterine cancer	1.97e-05	0.000397	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism—AKR1C3—uterine cancer	1.94e-05	0.00039	CbGpPWpGaD
Abiraterone—CYP17A1—Metabolism—MTHFR—uterine cancer	1.88e-05	0.000378	CbGpPWpGaD
Abiraterone—SULT2A1—Metabolism—EP300—uterine cancer	1.88e-05	0.000378	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—STAR—uterine cancer	1.87e-05	0.000377	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—AKR1B1—uterine cancer	1.87e-05	0.000377	CbGpPWpGaD
Abiraterone—ALB—Metabolism—AKR1B1—uterine cancer	1.86e-05	0.000375	CbGpPWpGaD
Abiraterone—ALB—Metabolism—STAR—uterine cancer	1.86e-05	0.000375	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	1.85e-05	0.000372	CbGpPWpGaD
Abiraterone—ALB—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	1.84e-05	0.00037	CbGpPWpGaD
Abiraterone—CYP17A1—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	1.66e-05	0.000333	CbGpPWpGaD
Abiraterone—ABCC1—Disease—CDKN2B—uterine cancer	1.61e-05	0.000325	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—STAR—uterine cancer	1.54e-05	0.000309	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—AKR1B1—uterine cancer	1.54e-05	0.000309	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism—STK11—uterine cancer	1.51e-05	0.000304	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism—CYP19A1—uterine cancer	1.51e-05	0.000304	CbGpPWpGaD
Abiraterone—ALB—Platelet activation, signaling and aggregation—VEGFA—uterine cancer	1.48e-05	0.000298	CbGpPWpGaD
Abiraterone—ABCC1—Disease—SMAD3—uterine cancer	1.47e-05	0.000297	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—POLD1—uterine cancer	1.47e-05	0.000296	CbGpPWpGaD
Abiraterone—ALB—Metabolism—POLD1—uterine cancer	1.46e-05	0.000294	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	1.42e-05	0.000285	CbGpPWpGaD
Abiraterone—ABCC1—Disease—FGFR2—uterine cancer	1.41e-05	0.000283	CbGpPWpGaD
Abiraterone—SULT2A1—Metabolism—PIK3CA—uterine cancer	1.39e-05	0.00028	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—SRD5A2—uterine cancer	1.39e-05	0.00028	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—NDUFB11—uterine cancer	1.39e-05	0.00028	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—AKR1C1—uterine cancer	1.37e-05	0.000276	CbGpPWpGaD
Abiraterone—ALB—Metabolism—AKR1C1—uterine cancer	1.37e-05	0.000275	CbGpPWpGaD
Abiraterone—ABCC1—Disease—MTHFR—uterine cancer	1.35e-05	0.000272	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism of lipids and lipoproteins—EP300—uterine cancer	1.35e-05	0.000272	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—RRM2—uterine cancer	1.22e-05	0.000246	CbGpPWpGaD
Abiraterone—ALB—Metabolism—RRM2—uterine cancer	1.22e-05	0.000245	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—POLD1—uterine cancer	1.21e-05	0.000243	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—DCN—uterine cancer	1.19e-05	0.000239	CbGpPWpGaD
Abiraterone—ALB—Metabolism—DCN—uterine cancer	1.18e-05	0.000238	CbGpPWpGaD
Abiraterone—ALB—Platelet activation, signaling and aggregation—PIK3CA—uterine cancer	1.16e-05	0.000233	CbGpPWpGaD
Abiraterone—SULT2A1—Metabolism—AKT1—uterine cancer	1.14e-05	0.000229	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism—MTHFR—uterine cancer	1.13e-05	0.000228	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—AKR1C1—uterine cancer	1.13e-05	0.000227	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—CYP11A1—uterine cancer	1.12e-05	0.000225	CbGpPWpGaD
Abiraterone—ALB—Metabolism—CYP11A1—uterine cancer	1.11e-05	0.000224	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—AKR1C3—uterine cancer	1.06e-05	0.000213	CbGpPWpGaD
Abiraterone—ALB—Metabolism—AKR1C3—uterine cancer	1.05e-05	0.000212	CbGpPWpGaD
Abiraterone—CYP17A1—Metabolism—PTEN—uterine cancer	1.05e-05	0.00021	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—RRM2—uterine cancer	1e-05	0.000202	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—AKR1B1—uterine cancer	1e-05	0.000202	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—STAR—uterine cancer	1e-05	0.000202	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	9.99e-06	0.000201	CbGpPWpGaD
Abiraterone—CYP17A1—Metabolism—EP300—uterine cancer	9.97e-06	0.000201	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—DCN—uterine cancer	9.76e-06	0.000196	CbGpPWpGaD
Abiraterone—ALB—Platelet activation, signaling and aggregation—AKT1—uterine cancer	9.44e-06	0.00019	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—CYP11A1—uterine cancer	9.19e-06	0.000185	CbGpPWpGaD
Abiraterone—ABCC1—Disease—ERBB2—uterine cancer	8.83e-06	0.000178	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—AKR1C3—uterine cancer	8.68e-06	0.000175	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—STK11—uterine cancer	8.24e-06	0.000166	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—CYP19A1—uterine cancer	8.24e-06	0.000166	CbGpPWpGaD
Abiraterone—ALB—Metabolism—STK11—uterine cancer	8.19e-06	0.000165	CbGpPWpGaD
Abiraterone—ALB—Metabolism—CYP19A1—uterine cancer	8.19e-06	0.000165	CbGpPWpGaD
Abiraterone—ABCC1—Disease—CDKN1B—uterine cancer	8.18e-06	0.000165	CbGpPWpGaD
Abiraterone—ALB—Hemostasis—EP300—uterine cancer	8.05e-06	0.000162	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—POLD1—uterine cancer	7.88e-06	0.000159	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	7.73e-06	0.000156	CbGpPWpGaD
Abiraterone—ABCC1—Disease—CTNNB1—uterine cancer	7.72e-06	0.000156	CbGpPWpGaD
Abiraterone—ALB—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	7.69e-06	0.000155	CbGpPWpGaD
Abiraterone—ALB—Hemostasis—VEGFA—uterine cancer	7.63e-06	0.000154	CbGpPWpGaD
Abiraterone—ALB—Hemostasis—NRAS—uterine cancer	7.53e-06	0.000152	CbGpPWpGaD
Abiraterone—ABCC1—Disease—PTEN—uterine cancer	7.53e-06	0.000152	CbGpPWpGaD
Abiraterone—CYP17A1—Metabolism—PIK3CA—uterine cancer	7.37e-06	0.000148	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism of lipids and lipoproteins—EP300—uterine cancer	7.37e-06	0.000148	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—AKR1C1—uterine cancer	7.37e-06	0.000148	CbGpPWpGaD
Abiraterone—ALB—Metabolism of lipids and lipoproteins—EP300—uterine cancer	7.33e-06	0.000148	CbGpPWpGaD
Abiraterone—ABCC1—Disease—EP300—uterine cancer	7.18e-06	0.000145	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—STK11—uterine cancer	6.76e-06	0.000136	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—CYP19A1—uterine cancer	6.76e-06	0.000136	CbGpPWpGaD
Abiraterone—ABCC1—Disease—NRAS—uterine cancer	6.72e-06	0.000135	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—RRM2—uterine cancer	6.57e-06	0.000132	CbGpPWpGaD
Abiraterone—ALB—Hemostasis—KRAS—uterine cancer	6.48e-06	0.000131	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—DCN—uterine cancer	6.38e-06	0.000128	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism—PTEN—uterine cancer	6.31e-06	0.000127	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—MTHFR—uterine cancer	6.19e-06	0.000125	CbGpPWpGaD
Abiraterone—ALB—Metabolism—MTHFR—uterine cancer	6.15e-06	0.000124	CbGpPWpGaD
Abiraterone—CYP17A1—Metabolism—AKT1—uterine cancer	6.02e-06	0.000121	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism—EP300—uterine cancer	6.01e-06	0.000121	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—CYP11A1—uterine cancer	6.01e-06	0.000121	CbGpPWpGaD
Abiraterone—ALB—Hemostasis—PIK3CA—uterine cancer	5.96e-06	0.00012	CbGpPWpGaD
Abiraterone—ABCC1—Disease—KRAS—uterine cancer	5.78e-06	0.000116	CbGpPWpGaD
Abiraterone—ALB—Hemostasis—TP53—uterine cancer	5.76e-06	0.000116	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—AKR1C3—uterine cancer	5.67e-06	0.000114	CbGpPWpGaD
Abiraterone—ALB—Hemostasis—HRAS—uterine cancer	5.51e-06	0.000111	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	5.45e-06	0.00011	CbGpPWpGaD
Abiraterone—ALB—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	5.42e-06	0.000109	CbGpPWpGaD
Abiraterone—ABCC1—Disease—PIK3CA—uterine cancer	5.31e-06	0.000107	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—MTHFR—uterine cancer	5.08e-06	0.000102	CbGpPWpGaD
Abiraterone—ABCC1—Disease—HRAS—uterine cancer	4.91e-06	9.89e-05	CbGpPWpGaD
Abiraterone—ALB—Hemostasis—AKT1—uterine cancer	4.87e-06	9.8e-05	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism—PIK3CA—uterine cancer	4.45e-06	8.96e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—CYP19A1—uterine cancer	4.42e-06	8.9e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—STK11—uterine cancer	4.42e-06	8.9e-05	CbGpPWpGaD
Abiraterone—ABCC1—Disease—AKT1—uterine cancer	4.34e-06	8.74e-05	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism—AKT1—uterine cancer	3.63e-06	7.32e-05	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—PTEN—uterine cancer	3.44e-06	6.93e-05	CbGpPWpGaD
Abiraterone—ALB—Metabolism—PTEN—uterine cancer	3.42e-06	6.89e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—MTHFR—uterine cancer	3.32e-06	6.69e-05	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—EP300—uterine cancer	3.28e-06	6.61e-05	CbGpPWpGaD
Abiraterone—ALB—Metabolism—EP300—uterine cancer	3.27e-06	6.57e-05	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—PTEN—uterine cancer	2.83e-06	5.69e-05	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—EP300—uterine cancer	2.7e-06	5.43e-05	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—PIK3CA—uterine cancer	2.43e-06	4.89e-05	CbGpPWpGaD
Abiraterone—ALB—Metabolism—PIK3CA—uterine cancer	2.42e-06	4.86e-05	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—PIK3CA—uterine cancer	1.99e-06	4.01e-05	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—AKT1—uterine cancer	1.98e-06	4e-05	CbGpPWpGaD
Abiraterone—ALB—Metabolism—AKT1—uterine cancer	1.97e-06	3.97e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—PTEN—uterine cancer	1.85e-06	3.72e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—EP300—uterine cancer	1.76e-06	3.55e-05	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—AKT1—uterine cancer	1.63e-06	3.28e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—PIK3CA—uterine cancer	1.3e-06	2.62e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—AKT1—uterine cancer	1.07e-06	2.14e-05	CbGpPWpGaD
